Anti-HIV agents. Can valproic acid help flush HIV from hiding?

ثبت نشده
چکیده

Researchers in Dallas, Texas, conducted an HIV eradication study and recently published an account of their work. Between 2002 and 2005, four PHAs whose viral load was very low (less than 50 copies) for several years, were enrolled in a study to try to reduce the level of HIV infection of their cells. In addition to their treatment regimens, all participants also received T-20 (enfuvirtide, Fuzeon) and the anti-seizure drug valproic acid. This last medication appears to help release HIV from resting T cells. After three months, researchers found that the level of HIV in resting cells fell significantly in three of the four PHAs. This is the first time that any therapy has appeared to reduce the body’s reservoir of HIV. The news of this development raised hopes that that a route to flushing HIV out of the body may be a possibility if the Dallas protocol were applied for several consecutive years.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Anti-HIV agents. Valproic acid and HIV eradication--many questions remain.

Although the amount of HIV in resting CD4+ cells clearly decreased when an intensive regimen of HAART and valproic acid was used, researchers are concerned that their laboratory equipment and techniques may not be sensitive enough to detect very low levels of latently infected cells. However, as interest in eradication studies grows, it is likely that HIV detection technologies and techniques w...

متن کامل

Design, Synthesis, Molecular Modeling Study and Biological Evaluation of New N'-arylidene-pyrido[2,3-d]pyrimidine-5-carbohydrazide Derivatives as Anti-HIV-1 Agents

In an attempt to identify potential new agents that are active against HIV-1, a series of novel pyridopyrimidine-5-carbohydrazide derivatives featuring a substituted benzylidene fragment were designed and synthesized based on the general pharmacophore of HIV-1 integrase inhibitors. The cytotoxicity profiles of these compounds showed no significant toxicity to human cells and they exhibited anti...

متن کامل

Design, Synthesis, Molecular Modeling Study and Biological Evaluation of New N'-arylidene-pyrido[2,3-d]pyrimidine-5-carbohydrazide Derivatives as Anti-HIV-1 Agents

In an attempt to identify potential new agents that are active against HIV-1, a series of novel pyridopyrimidine-5-carbohydrazide derivatives featuring a substituted benzylidene fragment were designed and synthesized based on the general pharmacophore of HIV-1 integrase inhibitors. The cytotoxicity profiles of these compounds showed no significant toxicity to human cells and they exhibited anti...

متن کامل

Drug- Resistance- Associated Mutations and HIV Sub-Type Determination in Drug-Naïve and HIV-Positive Patients under Treatment with Antiretroviral Drugs

Abstract Background and Objective: Resistance to antiretroviral agents is a significant concern in clinical management of HIV-infected individuals. Resistance is the result of mutations that develops in the viral protein targeted by antiretroviral agents. Material and Methods: In this cross-sectional study, the blood samples of 40 HIV-positive patients were collected. Twenty of them were d...

متن کامل

Molecular Docking and QSAR Study of 2-Benzoxazolinone, Quinazoline and Diazocoumarin Derivatives as Anti-HIV-1 Agents

A series of 2-benzoxazolinone, diazocoumarin and quinazoline derivatives have been shown to inhibit HIV replication in cell culture. To understand the pharmacophore properties of selected molecules and design new anti-HIV agents, quantitative structure–activity relationship (QSAR) study was developed using a descriptor selection approach based on the stepwise method. Multiple linear regression ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • TreatmentUpdate

دوره 17 6  شماره 

صفحات  -

تاریخ انتشار 2005